BRPI0415639A - formas de dosagem de oxicodona de liberação controlada, oral, uma vez por dia - Google Patents

formas de dosagem de oxicodona de liberação controlada, oral, uma vez por dia

Info

Publication number: BRPI0415639A
Authority: BR; Brazil
Prior art keywords: profiles; dosage forms; controlled release; oral dosage; once daily
Prior art date: 2003-10-29

Application number

BRPI0415639-0A

Other languages

English (en)

Portuguese (pt)

Inventor

Stephen Hwang

Padmaja Shivanand

Nisht B Modi

Original Assignee

Alza Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-10-29

Filing date

2004-10-28

Publication date

2006-12-12

2004-10-28 Application filed by Alza Corp filed Critical Alza Corp

2006-12-12 Publication of BRPI0415639A publication Critical patent/BRPI0415639A/pt

Links

BRUQQQPBMZOVGD-XFKAJCMBSA-N Oxycodone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4C BRUQQQPBMZOVGD-XFKAJCMBSA-N 0.000 title abstract 2
238000013270 controlled release Methods 0.000 title abstract 2
229960002085 oxycodone Drugs 0.000 title abstract 2
239000006186 oral dosage form Substances 0.000 title 1
239000002552 dosage form Substances 0.000 abstract 2
238000001727 in vivo Methods 0.000 abstract 2
230000002411 adverse Effects 0.000 abstract 1
230000002051 biphasic effect Effects 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Emergency Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

BRPI0415639-0A 2003-10-29 2004-10-28 formas de dosagem de oxicodona de liberação controlada, oral, uma vez por dia BRPI0415639A (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US51588003P	2003-10-29	2003-10-29
PCT/US2004/036132 WO2005041968A2 (en)	2003-10-29	2004-10-28	Once-a-day, oral, controlled-release, oxycodone dosage forms

Publications (1)

Publication Number	Publication Date
BRPI0415639A true BRPI0415639A (pt)	2006-12-12

Family

ID=34549453

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0415639-0A BRPI0415639A (pt)	2003-10-29	2004-10-28	formas de dosagem de oxicodona de liberação controlada, oral, uma vez por dia

Country Status (14)

Country	Link
EP (1)	EP1677798A2 (es)
JP (1)	JP2007509979A (es)
KR (1)	KR20060108690A (es)
CN (1)	CN1933837A (es)
AU (1)	AU2004285547A1 (es)
BR (1)	BRPI0415639A (es)
CA (1)	CA2546691A1 (es)
EC (1)	ECSP066534A (es)
IL (1)	IL175193A0 (es)
MA (1)	MA28215A1 (es)
NO (1)	NO20062398L (es)
RU (1)	RU2006118323A (es)
WO (1)	WO2005041968A2 (es)
ZA (1)	ZA200604310B (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU764453B2 (en)	1999-10-29	2003-08-21	Euro-Celtique S.A.	Controlled release hydrocodone formulations
US10179130B2 (en)	1999-10-29	2019-01-15	Purdue Pharma L.P.	Controlled release hydrocodone formulations
MXPA03003895A (es)	2000-10-30	2003-07-28	Euro Celtique Sa	Formulaciones de hidrocodona de liberacion controlada.
UA81224C2 (uk) *	2001-05-02	2007-12-25	Euro Celtic S A	Дозована форма оксикодону та її застосування
US20110104214A1 (en)	2004-04-15	2011-05-05	Purdue Pharma L.P.	Once-a-day oxycodone formulations
US7776314B2 (en)	2002-06-17	2010-08-17	Grunenthal Gmbh	Abuse-proofed dosage system
DE102004032051A1 (de)	2004-07-01	2006-01-19	Grünenthal GmbH	Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
DE10336400A1 (de)	2003-08-06	2005-03-24	Grünenthal GmbH	Gegen Missbrauch gesicherte Darreichungsform
DE102005005446A1 (de)	2005-02-04	2006-08-10	Grünenthal GmbH	Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10361596A1 (de)	2003-12-24	2005-09-29	Grünenthal GmbH	Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US20070048228A1 (en)	2003-08-06	2007-03-01	Elisabeth Arkenau-Maric	Abuse-proofed dosage form
US8075872B2 (en)	2003-08-06	2011-12-13	Gruenenthal Gmbh	Abuse-proofed dosage form
DE102004032049A1 (de)	2004-07-01	2006-01-19	Grünenthal GmbH	Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de)	2005-02-04	2006-08-10	Grünenthal GmbH	Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
SA07280459B1 (ar)	2006-08-25	2011-07-20	بيورديو فارما إل. بي.	أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
DE102007011485A1 (de)	2007-03-07	2008-09-11	Grünenthal GmbH	Darreichungsform mit erschwertem Missbrauch
KR101616246B1 (ko)	2008-01-25	2016-05-02	그뤼넨탈 게엠베하	약제학적 투여형
US9226907B2 (en)	2008-02-01	2016-01-05	Abbvie Inc.	Extended release hydrocodone acetaminophen and related methods and uses thereof
AU2009243681B2 (en)	2008-05-09	2013-12-19	Grunenthal Gmbh	Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
TWI473628B (zh)	2009-07-22	2015-02-21		用於對氧化敏感之類鴉片藥劑之抗破壞劑型
WO2011009602A1 (en)	2009-07-22	2011-01-27	Grünenthal GmbH	Hot-melt extruded controlled release dosage form
US20110150989A1 (en) *	2009-12-22	2011-06-23	Mallinkckrodt Inc.	Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans
JP5905872B2 (ja) *	2010-04-07	2016-04-20	ルピン・リミテッド	タペンタドールの制御放出医薬組成物
CA2808219C (en)	2010-09-02	2019-05-14	Gruenenthal Gmbh	Tamper resistant dosage form comprising inorganic salt
WO2012028318A1 (en)	2010-09-02	2012-03-08	Grünenthal GmbH	Tamper resistant dosage form comprising an anionic polymer
ES2648129T3 (es)	2011-07-29	2017-12-28	Grünenthal GmbH	Pastilla a prueba de manipulación que proporciona una liberación inmediata de un medicamento
AU2012289764B2 (en)	2011-07-29	2017-03-02	Grünenthal GmbH	Tamper-resistant tablet providing immediate drug release
US20130225697A1 (en)	2012-02-28	2013-08-29	Grunenthal Gmbh	Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
PL2838512T3 (pl)	2012-04-18	2018-12-31	Grünenthal GmbH	Farmaceutyczna postać dawkowania odporna na niewłaściwe użycie i odporna na uderzeniowe uwalnianie dawki
US10064945B2 (en)	2012-05-11	2018-09-04	Gruenenthal Gmbh	Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
JP6466417B2 (ja)	2013-05-29	2019-02-06	グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング	二峰性放出プロファイルを有する改変防止（ｔａｍｐｅｒ−ｒｅｓｉｓｔａｎｔ）剤形
AU2014273227B2 (en)	2013-05-29	2019-08-15	Grunenthal Gmbh	Tamper-resistant dosage form containing one or more particles
JP6449871B2 (ja)	2013-07-12	2019-01-09	グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング	エチレン−酢酸ビニルポリマーを含有する改変防止剤形
EP3073994A1 (en)	2013-11-26	2016-10-05	Grünenthal GmbH	Preparation of a powdery pharmaceutical composition by means of cryo-milling
EP3142646A1 (en)	2014-05-12	2017-03-22	Grünenthal GmbH	Tamper resistant immediate release capsule formulation comprising tapentadol
EA201692388A1 (ru)	2014-05-26	2017-05-31	Грюненталь Гмбх	Лекарственная форма в виде множества частиц, защищенная от вызываемого этанолом сброса дозы
BR112017021475A2 (pt)	2015-04-24	2018-07-10	Gruenenthal Gmbh	forma de dosagem resistente à adulteração (tamper) com liberação imediata e resistência contra extração de solvente
WO2017042325A1 (en)	2015-09-10	2017-03-16	Grünenthal GmbH	Protecting oral overdose with abuse deterrent immediate release formulations
TWI777658B (zh)	2016-08-10	2022-09-11	瑞士商赫孚孟拉羅股份公司	包含Akt蛋白質激酶抑制劑之醫藥組合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5914131A (en) *	1994-07-07	1999-06-22	Alza Corporation	Hydromorphone therapy
UA81224C2 (uk) *	2001-05-02	2007-12-25	Euro Celtic S A	Дозована форма оксикодону та її застосування
WO2003092648A1 (en) *	2002-04-29	2003-11-13	Alza Corporation	Methods and dosage forms for controlled delivery of oxycodone
CN1671358A (zh) *	2002-05-31	2005-09-21	阿尔扎公司	用于渗透传递可变剂量的羟考酮的剂型和组合物

2004
- 2004-10-28 EP EP04817492A patent/EP1677798A2/en not_active Withdrawn
- 2004-10-28 WO PCT/US2004/036132 patent/WO2005041968A2/en not_active Ceased
- 2004-10-28 AU AU2004285547A patent/AU2004285547A1/en not_active Abandoned
- 2004-10-28 JP JP2006538357A patent/JP2007509979A/ja not_active Withdrawn
- 2004-10-28 CN CNA2004800394188A patent/CN1933837A/zh active Pending
- 2004-10-28 BR BRPI0415639-0A patent/BRPI0415639A/pt not_active IP Right Cessation
- 2004-10-28 CA CA002546691A patent/CA2546691A1/en not_active Abandoned
- 2004-10-28 RU RU2006118323/15A patent/RU2006118323A/ru unknown
- 2004-10-28 KR KR1020067010336A patent/KR20060108690A/ko not_active Withdrawn
2006
- 2006-04-25 IL IL175193A patent/IL175193A0/en unknown
- 2006-04-28 MA MA28979A patent/MA28215A1/fr unknown
- 2006-04-28 EC EC2006006534A patent/ECSP066534A/es unknown
- 2006-05-26 ZA ZA200604310A patent/ZA200604310B/en unknown
- 2006-05-26 NO NO20062398A patent/NO20062398L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
KR20060108690A (ko)	2006-10-18
NO20062398L (no)	2006-07-27
ECSP066534A (es)	2006-11-24
CA2546691A1 (en)	2005-05-12
IL175193A0 (en)	2008-04-13
EP1677798A2 (en)	2006-07-12
WO2005041968A2 (en)	2005-05-12
WO2005041968A3 (en)	2006-06-22
JP2007509979A (ja)	2007-04-19
AU2004285547A1 (en)	2005-05-12
CN1933837A (zh)	2007-03-21
ZA200604310B (en)	2007-11-28
MA28215A1 (fr)	2006-10-02
RU2006118323A (ru)	2007-12-10

Legal Events

Date	Code	Title	Description
2012-05-15	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.
2012-10-09	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.

Publication	Publication Date	Title
BRPI0415639A (pt)	2006-12-12	formas de dosagem de oxicodona de liberação controlada, oral, uma vez por dia
EP1670450B8 (en)	2011-03-23	Pharmaceutical compositions and method of using levodopa and carbidopa
TW200505881A (en)	2005-02-16	Tri(cyclo) substituted amide compounds
WO2005041924A3 (en)	2005-11-10	Administration of levodopa and carbidopa
GEP20125701B (en)	2012-12-10	Application of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethyl]-4-fluoro-benzonitrile
WO2010009892A8 (en)	2011-02-24	Compositions for the treatment of pain and/or inflamation
TW200716628A (en)	2007-05-01	Novel compounds
GEP20247585B (en)	2024-01-25	Furoindazole derivatives
MX2010002733A (es)	2010-04-09	Terapia de intervalo para el tratamiento de tinnitus.
EA200401227A1 (ru)	2005-04-28	Система доставки лекарства с контролируемым высвобождением, включающая правастатин
MY135829A (en)	2008-07-31	Analeptic and drug combinations
CY1118967T1 (el)	2018-01-10	Φαρμακευτικες συνθεσεις υψηλης δοσης βιοτινης
EA200702522A1 (ru)	2008-04-28	Система доставки лекарств в полость рта и способы ее применения
PT1638582E (pt)	2009-05-28	Uso de ácido hialurónico para a preparação de composições para o tratamento de aftas recorrentes da cavidade bucal
IS7492A (is)	2004-10-07	Lyfjablöndu uppskriftir, sem innifela melantónín
ZA201000581B (en)	2011-04-28	1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazepine-7-carboxamide derivatives,preparation and therapeutic use thereof
ATE410152T1 (de)	2008-10-15	Therapeutisches system mit amoxicillin und clavulansäure
CL2008002223A1 (es)	2009-08-07	Compuestos derivados de 9-desoxo-9a-metil-9a-aza-9a-homoeritromicina a 2'-o-sustituida; proceso de preparación; compuesto intermediario; composición farmacéutica; y su uso en el tratamiento y/o profilaxis de la malaria.
HRP20090513T1 (hr)	2009-10-31	S-mirtazapin, namijenjen liječenju napadaja vrućine
EA200501565A1 (ru)	2006-06-30	Предназначенная для перорального приёма лекарственная форма для антагонистов протонного насоса
MY140194A (en)	2009-11-30	Novel fusidic acid derivatives
TW200626140A (en)	2006-08-01	Preventing vertical endoparasite infections
NO20065791L (no)	2007-01-30	Asyklovir-formuleringer
SE0203817D0 (sv)	2002-12-20	New composition
BRPI0415428A (pt)	2006-12-05	formulações terapêuticas